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Background
Apoptosis is an essential cellular process involved in
multiple diseases and a major pathway for neuronal
death in neurodegeneration. The detailed signaling
events/pathways that lead to apoptosis, especially in
neurons, require further elucidation.
Results
Here we find that a mitochondrial solute carrier family
protein, appoptosin, induces reactive oxygen species
release and intrinsic caspase-dependent apoptosis. The
physiological function of appoptosin is to transport/
exchange glycine/5-amino-levulinic acid across the mito-
chondrial membrane for heme synthesis. Alzheimer’s
b-amyloid precursor protein interacts with appoptosin
and modulates appoptosin-induced apoptosis. Levels of
appoptosin are upregulated in brain samples from
Alzheimer’s disease and infarct patients and in rodent
stroke models, as well as in cells treated with b-amyloid
(Ab) and glutamate. Downregulation of appoptosin pre-
vents the cell death and caspase activation caused by
glutamate or Ab insults.
Conclusion
Our study identifies appoptosin as a crucial player in
apoptosis and a novel proapoptotic protein involved in
neuronal cell death, providing a possible new therapeu-
tic target for neurodegenerative disorders and cancers.
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